Skip to main content
. 2022 Aug 11;11(8):1560. doi: 10.3390/antiox11081560

Table 3.

Background nutrient intake in the placebo and PMBE group at baseline, 6 weeks and 12 weeks (post-intervention) and mean change from baseline to 12 weeks post-intervention (∆) 1.

Time
Nutrients Baseline 6-Weeks 12-Weeks
Energy (kJ)
   Placebo 8554.9 (391.5) 8489.3 (373.6) 8452.4 (421.1) −102.4 (327.3)
   PMBE 8307.1 (359.2) 8364.8 (434.8) 8689.8 (356.8) 371.3 (318.8)
Protein (%E) 2
   Placebo 18.8 (0.8) 19.0 (0.9) 19.1 (0.9) 0.2 (0.9)
   PMBE 18.7 (0.5) 17.4 (0.8) 17.5 (0.7) −1.2 (0.6)
CHO (%E)
   Placebo 39.1 (1.4) 38.3 (1.4) 39.1 (1.6) 0.08 (1.3)
   PMBE 39.3 (1.4) 39.9 (1.3) 40.0 (1.3) 1.0 (1.4)
Fat (%E)
   Placebo 36.1 (1.3) 35.9 (1.5) 35.7 (1.5) −0.5 (1.3)
   PMBE 36.0 (1.1) 35.2 (1.1) 35.4 (0.9) −0.7 (1.2)
Sat Fat (%E)
   Placebo 13.0 (0.7) 13.3 (0.8) 13.2 (0.8) 0.2 (0.8)
   PMBE 13.5 (0.6) 13.0 (0.6) 13.1 (0.5) −0.5 (0.6)
Trans fat (%E)
   Placebo 0.6 (0.08) 0.5 (0.05) 0.6 (0.04) −0.04 (0.08)
   PMBE 0.6 (0.04) 0.6 (0.04) 0.6 (0.04) −0.05 (0.05)
Cholesterol (mg)
   Placebo 328.1 (41.1) 288.7 (31.6) 306.3 (27.5) −21.8 (42.9)
   PMBE 363.3 (26.9) 288.4 (29.3) 314.7 (26.3) −32.9 (27.7)
Sugars (g)
   Placebo 91.6 (6.9) 91.3 (5.2) 90.4 (5.7) −1.2 (6.3)
   PMBE 90.9 (6.3) 93.3 (7.0) 93.7 (6.8) 3.5 (6.1)
Fibre (g)
   Placebo 29.0 (1.9) 28.9 (1.9) 29.1 (2.4) 0.06 (1.5)
   PMBE 28.0 (1.6) 27.6 (1.5) 28.2 (1.5) 0.2 (1.7)
Sodium (mg)
   Placebo 2417.9 (164.3) 1984.1 (116.4) 2094.7 (133.3) −323.1 (197.4)
   PMBE 2365.9 (118.8) 2247.3 (167.9) 2520.6 (192.3) 174.8 (213.5)
Alcohol (g)
   Placebo 7.6 (2.8) 9.9 (3.0) 8.4 (2.3) 0.8 (1.5)
   PMBE 7.7 (1.8) 10.9 (2.5) 10.5 (1.9) 2.3 (2.0)

Dietary data from 3-day food diaries were evaluated using FoodWorks, Xyris®, Professional Edition Version 10.0.4266. Values are reported as mean (SEM). Independent samples t-test was used to compare baseline data and mean change data across groups. Paired samples t-test was used to compare change from baseline to post-intervention within groups. 1 Baseline data are for all participants who commenced the trial (n = 30 placebo, n = 32 intervention). For the active group, data at 6 weeks represent 31 participants and data at 12 weeks represent 30 participants who remained in the trial at the timepoints. 2 Data are presented for participants who completed the trial (N = 60). CHO, carbohydrates; PMBE, Pinus massoniana bark extract; %E refers to the percentage of dietary energy that is contributed by the relevant macronutrient; ∆, change from baseline to post-intervention.